Cybin Inc.HELP

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$12.59
Market cap
—
P/E
—
Revenue (FY)
—
Net income
-$113.1M
Dividend yield
—
1-year total return
114.8%
Net margin
—
Revenue growth
—
Debt / equity
—

What Cybin Inc. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue—$864,000$0———
Net income—-$32.2M-$67.6M-$47.5M-$78.1M-$113.1M
Free cash flow—-$19.2M-$45.3M-$47.6M-$68.9M—

More on HELP.

Figures from Cybin Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.